Breast screening and assessment of a breast symptom serve different purposes. Screening may be offered to people without symptoms according to age and risk; a new change needs a clinical evaluation regardless of the screening timetable.
If you have a symptom, say so when booking
A lump, skin dimpling, a new nipple change, unexplained discharge or persistent focal concern should not be booked only as a routine screening package. Explain what you have noticed so the appointment can be arranged appropriately. A previous normal mammogram does not remove the need to assess a new change.
Ask which imaging is appropriate
The clinician considers age, symptoms, examination, pregnancy or breastfeeding and previous findings when selecting tests. Mammography and ultrasound provide different information and are not automatically interchangeable. Further imaging or a tissue sample may be needed in some situations.
Discuss individual risk
Bring family history and previous biopsy or imaging reports. If there is a significant inherited-risk concern, ask whether a specialist risk assessment is appropriate. Do not assume that no family history means no risk, or that family history alone determines the meaning of a new lump.
Confirm how results will be reviewed
Ask who will explain the findings and what to do if a symptom persists despite reassuring tests. Keep the actual reports for future comparison. For routine screening, ask about expected benefits, limitations and the possibility of further tests after a recall. The aim is appropriate assessment and follow-up, not reassurance from a single test considered in isolation from symptoms and history.
Sources & further reading
International resources provide background information. Your clinician can explain the approach, screening schedule and requirements relevant to you in India.
General information cannot diagnose a condition or replace personal medical advice. For severe or rapidly worsening symptoms, seek urgent medical care.
The archive date organises this collection. This guide was first published on 29 October 2026.
